Top headlines: Indian SPACs to raise $1 bn, SII to double vax production

Business Standard brings you the top headlines on Monday

Indian SPACs to raise nearly $1 billion through IPOs in US stock market

At least four SPACs set up by Indian sponsors and their global partners are raising close to $1 billion through IPOs in the US stock market in the next few months. And they are focusing on domestic companies in areas such as media and entertainment, technology (tech), and consumer goods, apart from other markets in Asia. Read more

Serum Institute may double production of AstraZeneca-Oxford vaccine in 2022

Serum Institute of India (SII) is likely to double the production of the AstraZeneca-Oxford vaccine from 100 million per month